Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​Now in effect! ​Preferred product for injectable treprostinil​​

November 3, 2021

​As of November 1, 2021, the generic injectable treprostinil product manufactured by Sandoz is considered Independence's preferred injectable treprostinil product for the treatment of pulmonary arterial hypertension. Generic drugs are FDA-approved to be safe and effective.

Our specialty pharmacy vendors currently distribute the Sandoz generic. This ensures that our network providers and their patients will have reliable access to the preferred product.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.